One analyst, as well as supporters of South Korean President Yoon Suk Yeol, says China backed Yoon's ouster in South Korea to ...

New York State lawmakers led by Minority Leader Ortt, Sens. Chan, Weber and Martins, launched bills to fix the MTA amid cost ...

Former President Yoon Suk Yeol said Sunday he will always stand by his supporters, two days after the Constitutional Court ...

Secretary Robert F. Kennedy Jr. won’t acknowledge the scientific consensus that childhood vaccines do not cause autism.  ...

Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be the nation’s health secretary, the head of biotech’s largest trade group ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

Rep. Don Bacon (R-Neb.) criticized President Trump’s ouster of the director of the National Security Agency, arguing that Gen ...

The Town of Tonawanda has formally accused members of its police force of violating the state's Taylor Law by participating ...

The high court said a juror in the multiple-homicide case should not have been removed, even though fellow panelists said he ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...